Efficacy of Next-Generation Sequencing in Identifying Genetic Markers for Prostate Cancer Risk
Background: Prostate cancer is one of the most prevalent cancers among men worldwide. The identification of genetic markers that contribute to the risk of prostate cancer can significantly enhance early diagnosis and personalized treatment strategies. Next-Generation Sequencing (NGS) has emerged as...
Saved in:
Main Authors: | Fahad H. Alaithan, Raghad H. Alaithan, Tauheed Ahmed |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Journal of Pharmacy and Bioallied Sciences |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/jpbs.jpbs_1083_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The known genetic variants of BRCA1, BRCA2 and NOD2 in pancreatitis and pancreatic cancer risk assessment
by: Jarosław Matykiewicz, et al.
Published: (2025-01-01) -
Integrating BRCA testing into routine prostate cancer care: a multidisciplinary approach by SIUrO and other Italian Scientific Societies
by: Giulia Mammone, et al.
Published: (2025-01-01) -
Low dose DNA methyltransferase inhibitors potentiate PARP inhibitors in homologous recombination repair deficient tumors
by: Romain Pacaud, et al.
Published: (2025-01-01) -
Genetic factors for breast carcinogenesis
by: Pedro Enrique Miguel-Soca, et al.
Published: (2016-12-01) -
Navigating complex choices through legitimation: Narrative strategies in risk-reduction mastectomy decision-making among unaffected women with genetic risk for breast cancer in Switzerland
by: Maria Caiata-Zufferey, et al.
Published: (2025-06-01)